World Health Organization members vote in favor of global pandemic agreement
FILE PHOTO: People wearing face protective masks watch the sunset from Griffith Observatory during a partial lockdown during the outbreak of the coronavirus disease (COVID-19), in Los Angeles, California, U.S., December 7, 2020. REUTERS/Mario Anzuoni/File Photo
By Olivia Le Poidevin
Members of the World Health Organization voted emphatically in favor of a potentially groundbreaking global treaty on improving pandemic preparedness at the World Health Assembly on Monday.
One hundred twenty-four countries voted in favor, after Slovakia called for a vote on Monday, as its COVID-19 vaccine sceptic prime minister demanded that his country challenge the adoption of the agreement. No countries voted against, while 11 countries, including Poland, Israel, Italy, Russia, Slovakia and Iran abstained.
"Governments from all over the world are making their countries, and our interconnected global community, more equitable, healthier and safer from the threats posed by pathogens and viruses of pandemic potential," said Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus.
The draft accord, which addresses structural inequities about how drugs or vaccines and health tools are developed, following lessons learned from the COVID-19 pandemic which killed millions of people in 2020-2022, will be formally adopted on Tuesday in a plenary session at the World Health Assembly in Geneva.
However, it will not formally come into effect until an annex on pathogen sharing is negotiated, which could take up to two years, after which states will have to ratify the accord.
Following three years of difficult negotiations, the agreement has been seen by many diplomats and analysts as a victory for global cooperation at a time when multilateral organizations like the WHO have been battered by sharp cuts in U.S. foreign funding.
U.S. negotiators left the discussions after President Donald Trump began a 12-month process of withdrawing the U.S. - by far the WHO's largest financial backer - from the agency when he took office in January. Given this, the U.S. would not be bound by the pact.
© Thomson Reuters 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Mainichi
4 hours ago
- The Mainichi
Doctors denounce continued COVID restrictions at Japan's hospitals
TOKYO (Kyodo) -- Much of the world may have moved on from the coronavirus pandemic, but a painful legacy lingers in Japan: hospitals continuing to restrict patient visitations, even in the case of people wishing to see terminally ill loved ones. In early 2025, Japan marked five years since its first COVID-19 case, after which the disease claimed more than 130,000 lives up until August 2024. Infections have reappeared in seasonal waves even after the government downgraded the threat in May 2023 and placed COVID-19 in the same risk category as seasonal influenza. For families who want to see hospitalized loved ones, Japan appears to be stuck in time. Hospital websites continue to post "COVID-19" bulletins about visitations such as requiring masks and temperature checks, setting time limits and restricting the number of visitors. Now a group of physicians and social workers is demanding the restrictions be abolished or curbed, calling them a violation of human rights. "It's unthinkable to me that they're still this strict," said a doctor in his 30s from the Tokyo metropolitan area on condition of anonymity, expressing a mixture of surprise and disgust at the continued COVID policies. In January, his wife's mother was hospitalized with cancer at a facility in Akita Prefecture, northeastern Japan. The hospital had said that visitation was only available for "two family members," and his wife was not permitted to see her own mother -- at least at first on hospital grounds. Hopeful they would be allowed to see her after she was moved to a restriction-eased palliative care ward in March, they went to Akita with their child to visit the wife's mother. But when the Tokyo doctor tried explaining to the hospital staff that "this might be the last time" for the woman to see her grandchild, they refused, arguing that children are not permitted due to their high risk of transmitting infection, saying rules are rules. However, after the family persisted, the hospital said the woman "can meet with anyone if she leaves the hospital temporarily." A "nursing taxi," a car service catering specifically for persons with special needs, was hastily arranged to bring her home where she was able to see her daughter, grandchild, family and friends. The doctor was not at all satisfied with the effort. "If this was supposed to be an infection control measure, the hospital's response contradicts itself," he said, adding even pets are allowed on hospital visitations. "How is it that patients are allowed to see their dogs and cats but not their grandchildren?" The doctor is an infectious disease specialist and was involved in the pandemic response at a Tokyo hospital. Looking at the situation overseas, he said, "Japan's restrictions on visitation are excessive. I think there is an aspect of the medical field here that thinks it is easier not to have hospital visitations." The health ministry has recommended that "consideration be given to ensuring opportunities for visits as much as possible, keeping in mind both the importance of visitations and infection-control measures," but has left specific policy measures to individual hospitals and medical facilities. Last fall, a group of doctors who comprise an association for post-COVID 19 medical and welfare issues examined the situation at university and Red Cross hospitals across the country. It found that most had some restrictions still in place. There were some that do not allow visitations at all. Kazuya Iwai, co-chair of the association and chief doctor of infection control at Shizuoka City Shizuoka Hospital in central Japan, says there are no restrictions at his hospital and children are also permitted to visit patients. Although the hospital does not require masks, there is no difference in infection rates compared with other hospitals, he adds. "There is no scientific evidence that visitation restrictions are effective in preventing the spread of infections," Iwai said. "It is an important right for hospitalized patients to visit their loved ones, but patients and their families are reluctant to say so because they feel an obligation since they are being cared for," he points out. Although there are moves to gradually ease restrictions, he warned, "If the easing is at the discretion of the hospitals, there is a risk that they will return to strict policies depending on their situations of infection and other factors. The public needs to raise its voice and speak out." "Not being able to see family members in their final days is a human rights violation. The disadvantages are far greater than the advantages," he said. (By Toru Ichikawa)
Nikkei Asia
a day ago
- Nikkei Asia
$500m pledge makes China top WHO donor after US withdrawal
China has pledged $500 million over five years to the World Health Organization, stepping in as the largest state donor after the United States' withdrawal from the United Nations health agency. Chinese Vice Premier Liu Guozhong made the commitment during the 78th World Health Assembly in Geneva. The pledge comes as the WHO grapples with its deepest financial crisis in decades, caused by President Donald Trump's decision in January to withdraw from the agency and stop funding. The U.S., previously the largest contributor, left a $600 million shortfall in the organization's 2025 budget.
Japan Today
a day ago
- Japan Today
FDA approves Moderna's new lower-dose COVID-19 vaccine
FILE - The U.S. Food and Drug Administration campus in Silver Spring, Md., is photographed on Oct. 14, 2015. (AP Photo/Andrew Harnik, File) The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target. The approval 'adds an important new tool to help protect people at high risk of severe disease from COVID-19,' Stephane Bancel, Moderna's CEO, said in a statement Saturday. The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus. That's the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials. Moderna's existing vaccine doesn't face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall. The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said. The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results. © Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
